Latest Aortic valve stenosis Stories

Multicenter study of new treatment for patients with severe aortic stenosis published in New England Journal of Medicine and reported at TCTOne-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented tomorrow as a Late...

WASHINGTON, Sept. 23 /PRNewswire/ -- One-year data from the PARTNER clinical trial, published yesterday in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented today as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium....

Implantation of a new bioprosthetic-tissue valve into the hearts of patients who have severe aortic stenosis and are too sick or too old for open-heart surgery has been found to both save lives and improve the quality of those lives, according to a new multicenter study, to be published online at 2 p.m. Pacific time today in the New England Journal of Medicine.The study will also be presented at 8 a.m. Pacific time at the Transcatheter Cardiovascular Therapeutics Conference in Washington,...

WASHINGTON, Sept. 22 /PRNewswire/ -- One-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented tomorrow as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium....

Study highlights:    * After aortic valve replacement, the size of enlarged hearts shrink faster in women than in men with narrowed aortic valves (aortic stenosis).    * Because of different genetic activity, men develop more fibrous tissue in their hearts, which may explain why women's heart size decreases faster.Heart enlargement caused by narrowed aortic valves regresses faster in elderly women than in men after aortic valve replacement, according to research reported in...

A new study shows that people with a common heart defect may also be more likely to have brain aneurysms. The study is published in the May 4, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.Up to two percent of the population is born with the heart defect called a bicuspid aortic valve (BAV). The aortic valve allows blood to flow from the heart to the aorta. It normally has three flaps that open and close to regulate blood flow. In people with a...

A significant number of people with heart disease will benefit from less invasive transcatheter heart valve replacements in future, finds a review of updated practices in CMAJ (Canadian Medical Association Journal).The most effective treatment for aortic stenosis, a common heart condition that shows with angina, loss of consciousness due to lack of blood flow, congestive heart failure, or sudden death, is valve replacement. However, large cohorts of people are never referred for this surgery...

MINNEAPOLIS, March 1 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced the first human robot assisted endoscopic aortic valve replacement in the Midwest using the daVinci® Surgical System from Intuitive Surgical (Nasdaq: ISRG) to implant the ATS 3f ® Aortic Bioprosthesis. The procedure was recently performed by Husam H. Balkhy, M.D., at the Wisconsin Heart Hospital in...

CLEVELAND, Ohio, January 19 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, introduces its new module for the ANGIO Mentor simulator, the Percutaneous Aortic Valve Replacement Module, which provides physicians with an opportunity to practice a revolutionary endovascular implantation of a bioprosthesis, without performing cardiac surgery. Percutaneous aortic valve replacement is an innovative minimally invasive technique for heart valve...

MINNEAPOLIS, Dec. 7 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced it has received CE Mark approval to distribute the ATS 3f Enable® Aortic Bioprosthesis in the European Union, indicating it is compliant with relevant European health, safety, and environmental protection legislation. The Enable valve is the first surgical aortic valve replacement approved for commercial use...